Volume expansion potentiates cardiac sympathetic afferent reflex in dogs

Department of Physiology and Biophysics, University of Nebraska College of Medicine, Omaha, Nebraska 68198-4575 Our previous study (27) showed that the cardiac sympathetic afferent reflex (CSAR) was enhanced in dogs with congestive heart failure. The aim of this study was to test whether blood volum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2001-02, Vol.280 (2), p.H576-H581
Hauptverfasser: Wang, Wei, Schultz, Harold D, Ma, Rong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Department of Physiology and Biophysics, University of Nebraska College of Medicine, Omaha, Nebraska 68198-4575 Our previous study (27) showed that the cardiac sympathetic afferent reflex (CSAR) was enhanced in dogs with congestive heart failure. The aim of this study was to test whether blood volume expansion, which is one characteristic of congestive heart failure, potentiates the CSAR in normal dogs. Ten dogs were studied with sino-aortic denervation and bilateral cervical vagotomy. Arterial pressure, left ventricular pressure, left ventricular epicardial diameter, heart rate, and renal sympathetic nerve activity were measured. Coronary blood flow was also measured and, depending on the experimental procedure, controlled. Blood volume expansion was carried out by infusion of isosmotic dextran into a femoral vein at 40 ml/kg at a rate of 50 ml/min. CSAR was elicited by application of bradykinin (5 and 50 µg) and capsaicin (10 and 100 µg) to the epicardial surface of the left ventricle. Volume expansion increased arterial pressure, left ventricular pressure, left ventricular diameter, and coronary blood flow. Volume expansion without controlled coronary blood flow only enhanced the RSNA response to the high dose (50 µg) of epicardial bradykinin (17.   3 ± 1.9 vs. 10.6 ± 4.8%, P  
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.2001.280.2.h576